Benefit of adjuvant chemotherapy for resected pathologic N1 non-small cell lung cancer is unrecognized: A subgroup analysis of the JBR10 trial
- Resource Type
- Article
- Source
- In
Seminars in Thoracic and Cardiovascular Surgery Summer 2024 36(2):261-270 - Subject
- Language
- ISSN
- 1043-0679